Literature DB >> 25336010

Mesenchymal chondrosarcoma diagnosed on FISH for HEY1-NCOA2 fusion gene.

Kunihiko Moriya1, Saori Katayama, Masaei Onuma, Takeshi Rikiishi, Masami Hosaka, Mika Watanabe, Tadashi Hasegawa, Yoji Sasahara, Shigeo Kure.   

Abstract

Mesenchymal chondrosarcoma (MC) is an extremely rare subtype of chondrosarcoma that has a small round-cell sarcoma with focal cartilaginous differentiation, often with a pericytomatous vascular pattern. The non-cartilaginous components are usually dominant, and such lesions might be confused with other small round-cell tumors. Recently, a tumor-specific HEY1-NCOA2 fusion gene was identified in MC. Here we report the case of a 9-year-old boy who was diagnosed with MC by detection of HEY1-NCOA2 fusion signals in almost 50% of tumor cells in tissue sections on fluorescence in situ hybridization (FISH). In this way, the tumor was definitively diagnosed as MC. This case suggests that the detection of the HEY1-NCOA2 fusion gene on FISH is of diagnostic value for MC.
© 2014 Japan Pediatric Society.

Entities:  

Keywords:  HEY1-NCOA2 fusion gene; fluorescence in situ hybridization; mesenchymal chondrosarcoma

Mesh:

Substances:

Year:  2014        PMID: 25336010     DOI: 10.1111/ped.12407

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  5 in total

Review 1.  Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.

Authors:  Marc El Beaino; Jason Roszik; John A Livingston; Wei-Lien Wang; Alexander J Lazar; Behrang Amini; Vivek Subbiah; Valerae Lewis; Anthony P Conley
Journal:  Curr Oncol Rep       Date:  2018-03-26       Impact factor: 5.075

Review 2.  Interstitial Deletions Generating Fusion Genes.

Authors:  Ioannis Panagopoulos; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

3.  Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.

Authors:  Wenqing Qi; Wojciech Rosikiewicz; Zhaohong Yin; Beisi Xu; Huihong Jiang; Shibiao Wan; Yiping Fan; Gang Wu; Lu Wang
Journal:  J Pathol       Date:  2022-04-26       Impact factor: 9.883

Review 4.  An update on mesenchymal tumours of the orbit with an emphasis on the value of molecular/cytogenetic testing.

Authors:  F Roberts; E M MacDuff
Journal:  Saudi J Ophthalmol       Date:  2018-03-06

5.  Primary mesenchymal chondrosarcoma of the kidney without HEY1-NCOA2 and IRF2BP2-CDX1 fusion: A case report and review.

Authors:  Atsushi Yamagishi; Osamu Ichiyanagi; Sei Naito; Hiromi Ito; Takanobu Kabasawa; Mitsunori Yamakawa; Norihiko Tsuchiya
Journal:  Oncol Lett       Date:  2019-11-22       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.